While segments such as angioplasty balloons, catheters, and stents are approaching market saturation, next-generation technologies will sustain the percutaneous coronary intervention (PCI) sector in Western Europe, according to a new report from Frost & Sullivan.
The market, which earned $2.02 billion (1.91 billion euros) in revenues in 2014, is expected to reach $2.12 billion (2 billion euros) in 2018, according to the company. The high incidence of cardiovascular diseases in Western Europe is driving demand for PCI procedures, and innovations in niche applications such as drug-eluting bioabsorbable stents will continue to open up new market opportunities, senior research analyst Parthasarathy Raghava said in a statement.
